MSInsight : Paving the Path towards Precision Oncology
CEO and co-founder Arnaud Dr. Cutivet: “MSI cancer cells are present in 4% of cancers, especially colorectal, stomach, and endometrial cancers. Early detection, particularly in colorectal cancer, means we can use immunotherapy effectively, potentially saving lives.”
Related
Sector Deep Dive: Inside France’s Ambitious Cybersecurity Sovereignty Strategy
France is betting over €1 billion to become a cybersecurity powerhouse. This in-depth Sector Deep Dive maps the nation’s integrated ecosystem—government, defense, ANSSI, startups, research, and corporate giants—driving its push for digital independence and global leadership.
French Companies Struggle with Cybersecurity Reality Check
A sweeping new study by Cybervadis and CESIN of 1,000 firms finds most have solid policies but weak proof. As Europe's cybersecurity regulation NIS2 expands oversight to thousands more companies, the gap between compliance on paper and verifiable protection is now a national competitiveness issue.
From Refugee to Tech Talent: How Sistech Helps Women Build Careers in Europe’s Digital Economy
In Europe, 81% of refugee women remain unemployed five years after arrival—twice the rate of men. With Sistech’s support, 71% of fellows achieve positive outcomes, from tech jobs to advanced training, proving diverse talent is waiting to be unlocked.
Inside TiHive: How a French Deeptech Startup Is Revolutionizing Quality Control, One Diaper at a Time
The Grenoble-based company just raised €8M to scale its terahertz-AI technology that can see inside products on production lines
Latest
How Cybersecurity Startup MokN Combats Phishing With Deceptive 'Fake Doors'
When stolen credentials breached his 'impenetrable' system, Gautier Bugeon had an insight: give attackers fake doors to try. His startup MokN raised €2.6M, hit $1M ARR in 16 months with half its clients being billion-dollar companies, and is now expanding to America.
When Bots Go Agentic: How AI Is Rewriting the Rules of Cybersecurity
The cyber arms race has accelerated: humans once led attacks, AI now augments them, and MOAIs may soon strike autonomously. The big question: can defenders evolve fast enough to match a threat that never sleeps and learns on the fly?
French Tech Funding Wire Oct 10: Filigran, Phagos, Diffusely & More!
Between Oct 6 and Oct 10 a total of 19 French Tech companies raised €123.6M including: Diffusely, Keenest, Kenko, RSight, Ewake, Purenat, Ficha, Diffly, Claimy, Jint, Skyld AI, Yomi Pharma, Extensee, vebo°, REasy, Beez Biotech, Biomunex Pharmaceuticals.
🛡️Special Edition: French Cybersecurity Takes Center Stage
France bets big on cybersecurity as global leaders gather in Monaco. Part 1 of our special edition maps the nation’s €1B cyber strategy—spanning government, defense, startups, and AI-driven innovation—while revealing a widening gap between policy promises and on-the-ground protection.